Evidence map›Paper›PMID 42711466›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Expert opinion on Alzheimer's disease diagnostics and management in Central Eastern European countries representing 88 million population.

Ninoslav Mimica, Laura Dumitrescu, Milica Gregorič Kramberger, Jakub Hort, Tibor Kovács, Katarina Popadić, Bogdan Ovidiu Popescu, Martin Rakuša, Konrad Rejdak, Peter Turčáni

Abstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ninoslav MimicaReferral Centre of Ministry of Health of Republic of Croatia for Alzheimer's Disease and Old Age Psychiatry, University Psychiatric Hospital Vrapče, Zagreb, Croatia. ninoslav.mimica@bolnica-vrapce.hr.ORCID http://orcid.org/0000-0003-4552-0547
Laura DumitrescuDepartment of Clinical Neurosciences, Carol Davila University of Medicine and Pharmacy, Department of Neurology; Laboratory of Cell Biology, Neurosciences and Experimental Myology, Victor Babes National Institute of Pathology, Colentina Clinical Hospital, Bucharest, Romania.ORCID http://orcid.org/0000-0001-5356-1096
Milica Gregorič KrambergerMedical Faculty, University of Ljubljana, Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0001-8231-1176
Jakub HortDepartment of Neurology, Charles University, Second Faculty of Medicine, Motol University Hospital, Praha, Czech Republic.ORCID http://orcid.org/0000-0002-1080-3726
Tibor KovácsDepartment of Neurology, Károly Schaffer Laboratory of Neuropathology, National Prion Reference Centre; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.ORCID http://orcid.org/0000-0002-8603-8848
Katarina PopadićDivision for Neurodegenerative Diseases and Neurogenomics, Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.ORCID http://orcid.org/0009-0003-8154-8130
Bogdan Ovidiu PopescuDepartment of Clinical Neurosciences, Carol Davila University of Medicine and Pharmacy, Department of Neurology; Laboratory of Cell Biology, Neurosciences and Experimental Myology, Victor Babes National Institute of Pathology, Colentina Clinical Hospital, Bucharest, Romania.ORCID http://orcid.org/0000-0003-4826-2598
Martin RakušaDivision of Neurology, Medical Research Department, University Medical Centre Maribor, Maribor, Slovenia.ORCID http://orcid.org/0000-0003-4433-3985
Konrad RejdakDepartment of Neurology, Medical University of Lublin, Lublin, Poland.ORCID http://orcid.org/0000-0002-7019-6681
Peter TurčániIst. Department of Neurology, Comenius University and University Hospital Bratislava, Bratislava, Slovakia.ORCID http://orcid.org/0000-0002-4868-6836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expert panel from Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia and Slovenia discussed the current situation of various topics related to the diagnostics, general management and treatment of Alzheimer's disease (AD) in these Central Eastern European (CEE) countries, representing around 88 million population. The aim was to estimate AD prevalence, confirm the presence of AD patients/caregivers' associations and AD registries, and establish the availability and reimbursement of costs for AD diagnostic biomarkers and treatment. The panel acknowledged similarities and differences among CEE countries and issued recommendations for cross specialty collaboration between experts in neurology, psychiatry and general practitioners for the early AD diagnosis. They also agreed that CEE countries should provide comprehensive education and training and encourage collaboration between health experts. The panel suggested that CEE countries should involve various stakeholders, policymakers, implement routine screening, combine advanced diagnostic tools and use telemedicine and remote monitoring technologies, invest in research to develop AI-based analyses, new AD diagnostic and monitoring methods, digital tools and wearables. The focus is to address the stigma, reimburse costs of diagnostic tests and therapy, and reduce the modifiable risk factors for AD.

Indexed as

Alzheimer DiseaseDisease ManagementEurope, EasternHumansAlzheimer’s diseaseCentral Eastern European countriesDiagnosticsManagementTreatment

Identifiers

PMID42711466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.